Stéphane Bancel, Moderna CEO (Steven Ferdman/Getty Images)

‘Plan­ning to vac­ci­nate every­one in the US,’ Mod­er­na out­lines ef­forts to sup­ply their Covid-19 vac­cine as man­u­fac­tur­ing ramps up ahead of PhI­II

Twelve days from the planned start of their Phase III piv­otal tri­al, the ex­ec­u­tive crew at Mod­er­na has set up the man­u­fac­tur­ing base need­ed to be­gin pro­duc­tion of the first 500,000 dos­es of their Covid-19 vac­cine with plans to feed it in­to a glob­al sup­ply chain. But the ini­tial batch­es will like­ly be ready in the US first, where com­pa­ny CEO Stéphane Ban­cel plans to be able to vac­ci­nate every­one.

“We have start­ed mak­ing com­mer­cial prod­uct at-risk, and will con­tin­ue to do so every day and every week of the month,” Ban­cel told an­a­lysts dur­ing their morn­ing call on the Phase I da­ta just pub­lished in the New Eng­land Jour­nal of Med­i­cine.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.